FairScope Lab
EN 繁中 简中

VRTX

Valuation Healthcare · Biotechnology Data as of 2026-06-30

P/E Ratio · Metrics

P/E Ratio

28.87

PEG Ratio

0.41

Dividend Yield

-

Gross Margin

85.33%

Net Margin

32.99%

Revenue CAGR 3Y

10.17%

ROE

21.73%

ROA

16.04%

Buyback Yield

0.23%

Current Ratio

3.19

Magic Earn Yield

4.61%

Altman Z-Score

12.09

Fair Value River

Score

Valuation 53
Profitability 65
Growth 34
Health 100
Yield 4
← Back to Dashboard